ESMO Young Oncologist Journal Club

The ESMO Young Oncologists Committee is proud to host the Young Oncologist Journal Club. On a regular basis (1-3 times a month), a committee member – or a specially invited young oncologists – provides you with an appraisal of an important clinical and/or translational article published in a major journal. The appraisers add their comments analysing the clinical relevance of the article and possible considerations.

Get involved by reading the review, share your thoughts and raise questions for discussion by logging in and commenting on the article. Commenting is reserved to ESMO Members only. We look forward to your input!

Submit an article


Topic Title Author
Melanoma and other skin tumours Genetic Alterations in Cutaneous Melanoma – what do we know? Teresa Amaral, Ioanna Tampouri
Genitourinary cancers Cabozantinib in Advanced Renal-Cell Carcinoma Cátia Faustino
Genitourinary cancers PD-1 Blockade Sets a New Benchmark in Previously Treated Metastatic Renal Cell Carcinoma (mRCC) Mehmet Akif Öztürk
Breast cancer Have a Look Around: breast cancer relapse may be printed in the blood Leticia De Mattos-Arruda
Lung and other thoracic tumours Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial Yusuke Okuma
Lung and other thoracic tumours CheckMate of Nivolumab as Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer Antonio Passaro and Raffaele Califano
Lung and other thoracic tumours Pembrolizumab Seems to be a New Immune Checkpoint Inhibitor Option for NSCLC, However is our Knowledge on Tumour Biomarkers Enough? Pedro Nazareth Aguiar Jr, Ramon Andrade de Mello
Lung and other thoracic tumours Ramucirumab as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer: have we got a new kid on the block? Antonio Passaro and Raffaele Califano
Lung and other thoracic tumours Ceritinib in ALK-Rearranged Non-Small-Cell Lung Cancer Matthew Howell and Raffaele Califano
Gynaecologic malignancies Bevacizumab Plus Chemotherapy for Metastatic Cervical Cancer: a step forward Ramon Andrade de Mello, Pedro Madureira
Sarcomas New Options for Treatment of Metastatic Sarcoma Pose a Challenge in Selecting the Best One Adel Aref
Lung and other thoracic tumours Prognostic and Predictive Value of Rare EGFR Exon 18 and Exon 20 Mutations in Advanced NSCLC Mohamed Alorabi
Gastrointestinal cancers Ramucirumab and the Evolving Role of Targeted Therapy in Advanced Gastric Cancer Adel Aref
Gastrointestinal cancers Panitumumab-Folfox4 Treatment and RAS Mutation in Colorectal Cancer Alfredo Addeo
Haematologic malignancies R-GCVP as First Line Treatment for DLBCL Patients with Cardiac Comorbidity Mohamed Alorabi